臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"tseng t c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 156-180 of 534 (22 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-09-04T06:11:55Z	Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation	Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:54Z	Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir	Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Hsu C.-S.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:54Z	Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin	Yu M.-L.; Liu C.-H.; Huang C.-F.; Tseng T.-C.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.-H.H.; Chuang W.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:53Z	Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: New trick of old dog	Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:52Z	Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion	Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:51Z	Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads	Tseng T.-C.; Liu C.-J.; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:51Z	Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients	Cheng H.-R.; Liu C.-J.; Tseng T.-C.; Su T.-H.; Yang H.-I.; Chen C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:50Z	Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection	Su T.-H.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:49Z	Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype	Huang C.-F.; Yu M.-L.; JIA-HORNG KAO; Tseng T.-C.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.H.H.; Chuang W.-L.; Liu C.-H.
臺大學術典藏	2021-09-04T06:11:48Z	Evolution of viral biomarkers in predicting outcomes of chronic hepatitis B patients: From DNA to surface antigen	Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:48Z	Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C	Su T.-H.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:45Z	Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: A multicentre study	Dai C.-Y.; Tseng T.-C.; Wong G.L.H.; Huang J-F.; Wong V.W.S.; Liu C.-J.; Yu M.-L.; Chuang W.-L.; JIA-HORNG KAO; Yuen Chan H.L.; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:45Z	Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:43Z	Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis	Wang C.-C.; Hsieh T.-C.; Tseng T.-C.; Wang P.-C.; Hsu C.-S.; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:43Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:41Z	Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:41Z	Peginterferon α in the treatment of chronic hepatitis B	Tseng T.-C.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:11:40Z	Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously	Cheng H.-R.; JIA-HORNG KAO; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; Su T.-H.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:38Z	A pilot study of add-on oral hypoglycemic agents in treatment-na?ve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin	Hsu C.-S.; Hsu S.-J.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:38Z	Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients	Wang C.-C.; Tseng T.-C.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	What can we learn from hepatitis B virus clinical cohorts?	Lin C.-L.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	Hepatitis B virus infection and metabolic syndrome: Fact or fiction?	Wang C.-C.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:34Z	Treating immune-tolerant Hepatitis B	Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:34Z	Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages	Liu C.-J.; Chen T.-C.; Chen P.-J.; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:31Z	Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients	Wang C.-C.; Liu C.-H.; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO

Showing items 156-180 of 534 (22 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2832427
	???header.visitor??? : 33775136 ???header.onlineuser??? : 1460 ???header.sponsordeclaration???